Comparative Study between Quantitative Digital Image Analysis and Fluorescence In Situ Hybridization of Breast Cancer Equivocal HER2 2+Cases

被引：0
|
作者：
Ayad, E. [1 ]
Mansy, M. [1 ]
Elwi, D. [1 ]
Salem, M. [1 ]
Salama, M. [2 ,3 ]
Kayser, K. [4 ]
机构：
[1] Cairo Univ, Dept Pathol, Fac Med, Cairo, Egypt
[2] Univ Utah, Dept Pathol, Salt Lake City, UT USA
[3] ARUP Reference Lab, Salt Lake City, UT USA
[4] Humboldt Univ, Dept Pathol, D-10099 Berlin, Germany
来源：
ANALYTICAL CELLULAR PATHOLOGY | 2014年 / 2014卷
关键词：
D O I：
10.1155/2014/608254
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Robust and accurate digital measurement for HER2 amplification in HER2 equivocal breast cancer diagnosis
    Wang, Yuefeng
    Tsang, Julia Y. S.
    Cui, Yongmei
    Cui, Ji
    Lin, Ying
    Zhao, Songli
    Law, Patrick T. W.
    Cheung, Sai Yin
    Ng, Enders K. O.
    Tse, Gary M. K.
    Ke, Zunfu
    SCIENTIFIC REPORTS, 2017, 7
  • [32] HER-2 gene amplification by fluorescence in situ hybridization (FISH) compared with immunohistochemistry (IHC) in breast cancer: a study of 528 equivocal cases
    Han Zhang
    Guoping Ren
    Xiaoling Wang
    Jing Zhao
    Hongtian Yao
    Yanfeng Bai
    Wang Bo
    Breast Cancer Research and Treatment, 2012, 134 : 743 - 749
  • [33] Rapid Fluorescence in Situ Hybridization (FISH) for HER2 Assessment in Breast and Gastroesophageal Cancer
    Dokus, B. J.
    Allen, S. F.
    Steinmetz, H. B.
    Marotti, J. D.
    Tsongalis, G. J.
    Tafe, L. J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2013, 15 (06): : 908 - 908
  • [34] Resolving the ERBB2 (HER2) Status of Invasive Breast Cancers with Double-Equivocal HER2 Status by Immunohistochemistry and Fluorescence In-situ Hybridization
    Hon, Jane Date
    Zhang, Xinmin
    Edmonston, Tina Bocker
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 146 : S96 - S96
  • [35] Analysis of equivocal HER2 FISH amplification in breast cancer
    Sung, S. H.
    Moon, B. I.
    HISTOPATHOLOGY, 2012, 61 : 30 - 30
  • [36] Instant-quality fluorescence in-situ hybridization as a new tool for HER2 testing in breast cancer: a comparative study
    Franchet, Camille
    Filleron, Thomas
    Cayre, Anne
    Mounie, Eveline
    Penault-Llorca, Frederique
    Jacquemier, Jocelyne
    MacGrogan, Gaetan
    Arnould, Laurent
    Lacroix-Triki, Magali
    HISTOPATHOLOGY, 2014, 64 (02) : 274 - 283
  • [37] Dual color chromogenic in situ hybridization for determination of HER2 status in breast cancer: a large comparative study to current state of the art fluorescence in situ hybridization
    Mollerup, Jens
    Henriksen, Ulla
    Mueller, Sven
    Schonau, Andreas
    BMC CLINICAL PATHOLOGY, 2012, 12
  • [38] Assessing HER2 Immunohistochemistry Using Digital Imaging Analysis and its Correlation with HER2 Fluorescence in Situ Hybridization Results
    Hartage, Ramon
    Yearsley, Kurtis
    Hammond, Scott
    Parwani, Anil
    Li, Zaibo
    LABORATORY INVESTIGATION, 2019, 99
  • [39] Assessing HER2 Immunohistochemistry Using Digital Imaging Analysis and its Correlation with HER2 Fluorescence in Situ Hybridization Results
    Hartage, Ramon
    Yearsley, Kurtis
    Hammond, Scott
    Parwani, Anil
    Li, Zaibo
    MODERN PATHOLOGY, 2019, 32
  • [40] Fully Automated Fluorescent in situ Hybridization (FISH) Staining and Digital Analysis of HER2 in Breast Cancer: A Validation Study
    van der Logt, Elise M. J.
    Kuperus, Deborah A. J.
    van Setten, Jan W.
    van den Heuvel, Marius C.
    Boers, James. E.
    Schuuring, Ed
    Kibbelaar, Robby E.
    PLOS ONE, 2015, 10 (04):
12345